Your session is about to expire
← Back to Search
Arm 2: Phase 1- Safety Lead-in (Cohort 2) for Lung Cancer
Study Summary
"This trial aims to determine if KSQ-001EX is safe for patients with advanced solid tumors."
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are new participants still eligible to enroll in this ongoing clinical trial?
"The current status of this clinical trial, as documented on clinicaltrials.gov, indicates that patient recruitment is not ongoing. Initially shared on July 31st, 2024, the latest update was made on January 25th, 2024. Despite this trial no longer accepting participants, there are a substantial number of other studies actively seeking enrollees - precisely 4915 at present."
Which individuals are eligible to partake in this experimental study?
"In order to be considered for this research, individuals must have a diagnosis of melanoma and fall within the age bracket of 18 to 70 years. The study has availability for up to 72 eligible participants."
Is the research study open to participants who are under 20 years old?
"Participants aged between 18 and 70 are being sought for enrolment in this clinical investigation. It is worth noting that there are a considerable number of trials available specifically for individuals under 18 years old as well as those over the age of 65, with figures standing at 395 and 4711 respectively."
Share this study with friends
Copy Link
Messenger